Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is celebrating the achievement of key milestones this year, which include an agreement with Abbott Diagnostics to establish in-store kiosks that utilize Avricore’s platform. This builds on an agreement with the Shoppers Drug Mart pharmaceutical chain that makes its platform accessible to patients across Canada. Avricore’s HealthTab(TM) platform is a testing and health data network that draws on data from blood samples and other samples to provide lab-quality results to patients in real-time. “Avricore’s efforts to provide access to the testing solution makes it possible for patients to seek out pharmacies in their local neighborhoods, often within walking distance, to gain insights on critical health conditions without the additional delays associated with getting clinic appointments and then having to visit a lab,” explains a recent article. “The key aims of Avricore’s focus on making a range of health innovations available through the community pharmacy are to improve health outcomes for patients and lower overall health care costs going forward. Reducing the cost of routine lab tests may ultimately help reduce costs for insurers.”
To view the full article, visit https://ibn.fm/tMPn2
About Avricore Health Inc.
Avricore Health is a pharmacy service innovator focused on acquiring and developing early stage technologies aimed at moving pharmacy forward. Through its flagship offering HealthTab(TM), (a wholly owned subsidiary), its mission is to make actionable health information more accessible to everyone by creating the world’s largest network of rapid testing devices in community pharmacies. For more information about the company, visit www.AvricoreHealth.com.
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork.